SOLENO THERAPEUTICS INC
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On April 17, 2024, in connection with the determination by the Board of Directors (the “Board”) of Soleno Therapeutics, Inc. (the “Company”) of the slate of director nominees to stand for election at the Company’s 2024 Annual Meeting of Stockholders (the “2024 AGM”), Gwen Melincoff, a current director, notified the Company that she does not intend to stand for re-election to the Board at the 2024 AGM.
Extracted from this filing and checked against the source text.
Gwen Melincoff departed as Director at SOLENO THERAPEUTICS INC.
On April 17, 2024, in connection with the determination by the Board of Directors (the “Board”) of Soleno Therapeutics, Inc. (the “Company”) of the slate of director nominees to stand for election at the Company’s 2024 Annual Meeting of Stockholders (the “2024 AGM”), Gwen Melincoff, a current director, notified the Company that she does not intend to stand for re-election to the Board at the 2024 AGM.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.